Latest Operational Update News

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

Coronado Global Resources has filed a detailed SEC Form 8-K revealing confidential discussions with noteholders and outlining its growth trajectory, liquidity management, and operational updates across its Australian and US metallurgical coal assets.

Cazaly Resources has addressed a sharp rise in its share price and trading volume, attributing the movement to strong gold and silver prices alongside a recent independent research report.

Krakatoa Resources has agreed to sell its non-core Belgravia Project in New South Wales for $350,000, redirecting capital to advance its strategic Zopkhito Antimony-Gold Project in Georgia, a critical minerals asset positioned to serve European markets.

Premier1 Lithium Limited’s PLCO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and market impact.

Australian Oil Company Limited has announced an $800,000 capital raising through a two-tranche share placement aimed at advancing its Californian oil and gas projects and exploring new growth opportunities.

MA Financial Group has reported a surge in assets under management and loan book growth alongside a major $525 million property acquisition, signaling robust momentum across its financial services divisions.

Barton Gold Holdings has secured $15 million through an institutional placement led by Franklin Templeton, with a $2.5 million Share Purchase Plan opening to shareholders. The capital raise supports the company’s goal to commission Stage 1 production by the end of 2026 in South Australia’s Gawler Craton.

Atlas Arteria reported a robust 10.9% increase in Q3 2025 toll revenue, driven by strong traffic growth across its global portfolio and strategic toll hikes. The company also appointed Kara Lawrence as CEO of Dulles Greenway, signaling a new leadership phase.

EPX Limited reported a net increase in Annual Contract Value to $18 million and a steady rise in Annual Recurring Revenue to $15.7 million for Q3 2025, driven by new contracts in the UAE healthcare sector and Australian commercial properties.

Wellnex Life reported an 18.2% sales decline in Q1 FY26 amid delayed IP licensing revenue and increased costs, while securing new debt facilities and exiting the medicinal cannabis segment.

Stockland has reaffirmed its FY26 financial guidance following a strong first quarter marked by solid sales in masterplanned and land lease communities and positive leasing outcomes across its commercial portfolio.